Role of RAGE and its ligand HMGB1 in the development of COPD

References

• Labaki WW, Rosenberg SR. Chronic obstructive pulmonary disease [J]. Ann Intern Med. 2020;173(3):Itc17–itc32.
   PubMed Web of Science ®Google Scholar
• Løkke A, Lange P, Scharling H, et al. Developing COPD: a 25 year follow up study of the general population [J]. Thorax. 2006;61(11):935–939.
   PubMed Web of Science ®Google Scholar
• SILVERMAN EK. Genetics of COPD [J]. Annu Rev Physiol. 2020;82(1):413–431.
   PubMed Web of Science ®Google Scholar
• Brightling C, Greening N. Airway inflammation in COPD: progress to precision medicine [J]. Eur Respir J. 2019;54(2):1900651.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. COPD 2020: new directions needed [J]. Am J Physiol Lung Cell Mol Physiol. 2020;319(5):L884–L886.
   PubMed Web of Science ®Google Scholar
• Yonchuk JG, SILVERMAN E, Bowler RP, et al. Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung [J]. Am J Respir Crit Care Med. 2015;192(7):785–792.
   PubMed Web of Science ®Google Scholar
• Sukkar MB, Ullah MA, WJ Gan, et al. RAGE: a new frontier in chronic airways disease [J]. Br J Pharmacol. 2012;167(6):1161–1176.
   PubMed Web of Science ®Google Scholar
• Erusalimsky JD. The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes [J]. Redox Biol. 2021;42:101958.
   PubMed Web of Science ®Google Scholar
• Wuren T, Huecksteadt T, Beck E, et al. The receptor for advanced glycation endproducts (RAGE) decreases survival of tumor-bearing mice by enhancing the generation of lung metastasis-associated myeloid-derived suppressor cells [J]. Cell Immunol. 2021;365:104379.
   PubMed Web of Science ®Google Scholar
• Yepuri G, Shekhtman A, Marieschmidt A, et al. Heme & RAGE: a new opportunistic relationship? [J]. FEBS J. 2021;288(11):3424–3427.
   PubMed Web of Science ®Google Scholar
• Serveaux-Dancer M, Jabaudon M, Creveaux I, et al. Pathological implications of receptor for advanced glycation end-product (ager) gene polymorphism [J]. Dis Markers 2019 2067353. DOI:10.1155/2019/2067353.
   PubMed Web of Science ®Google Scholar
• Hudson BI, ME Lippman. Targeting RAGE signaling in inflammatory disease [J]. Annu Rev Med. 2018;69(1):349–364.
   PubMed Web of Science ®Google Scholar
• Fritz G. RAGE: a single receptor fits multiple ligands [J]. Trends Biochem Sci. 2011;36(12):625–632.
   PubMed Web of Science ®Google Scholar
• Bongarzone S, Savickas V, Luzi F, et al. Targeting the receptor for advanced glycation endproducts (rage): a medicinal chemistry perspective [J]. J Med Chem. 2017;60(17):7213–7232.
   PubMed Web of Science ®Google Scholar
• Ishihara K, Tsutsumi K, Kawane S, et al. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site [J]. FEBS Lett. 2003;550(1–3):107–113.
   PubMed Web of Science ®Google Scholar
• Manigrasso MB, PAN J, RAI V, et al. Small molecule inhibition of ligand-stimulated RAGE-DIAPH1 signal transduction [J]. Sci Rep. 2016;6(1):22450.
   PubMed Web of Science ®Google Scholar
• ZHANG L, Bukulin M, Kojro E, et al. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases [J]. J Biol Chem. 2008;283(51):35507–35516.
   PubMed Web of Science ®Google Scholar
• Raucci A, Cugusi S, ANTONELLI A, et al. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10) [J]. FASEB J. 2008;22(10):3716–3727.
   PubMed Web of Science ®Google Scholar
• Prasad K, DHAR I, CASPAR-BELL G. Role of advanced glycation end products and its receptors in the pathogenesis of cigarette smoke-induced cardiovascular disease [J]. Int J Angiol. 2015;24(2):75–80.
   PubMedGoogle Scholar
• REYNOLDS PR, STOGSDILL JA, STOGSDILL MP, et al. Up-regulation of receptors for advanced glycation end-products by alveolar epithelium influences cytodifferentiation and causes severe lung hypoplasia [J]. Am J Respir Cell Mol Biol. 2011;45(6):1195–1202.
   PubMed Web of Science ®Google Scholar
• Winden DR, Ferguson NT, Bukey BR, et al. Conditional over-expression of RAGE by embryonic alveolar epithelium compromises the respiratory membrane and impairs endothelial cell differentiation. Respir Res. 2013 Oct 17 14(1):108.
   PubMed Web of Science ®Google Scholar
• Fineschi S, De Cunto G, Facchinetti F, et al. Receptor for advanced glycation end products contributes to postnatal pulmonary development and adult lung maintenance program in mice [J]. Am J Respir Cell Mol Biol. 2013;48(2):164–171.
   PubMed Web of Science ®Google Scholar
• BODINE BG, BENNION BG, Leatham E, et al. Conditionally induced RAGE expression by proximal airway epithelial cells in transgenic mice causes lung inflammation. Respir Res. 2014 Oct 29 15(1):133.
   PubMed Web of Science ®Google Scholar
• STOGSDILL MP, STOGSDILL JA, BODINE BG, et al. Conditional overexpression of receptors for advanced glycation end-products in the adult murine lung causes airspace enlargement and induces inflammation [J]. Am J Respir Cell Mol Biol. 2013;49(1):128–134.
   PubMed Web of Science ®Google Scholar
• Wolf L, Herr C, Niederstrasser J, et al. Receptor for advanced glycation endproducts (RAGE) maintains pulmonary structure and regulates the response to cigarette smoke [J]. PLoS One. 2017;12(7):e0180092.
   PubMed Web of Science ®Google Scholar
• AL-ROBAIY S, Weber B, Simm A, et al. The receptor for advanced glycation end-products supports lung tissue biomechanics [J]. Am J Physiol Lung Cell Mol Physiol. 2013;305(7):L491–500.
   PubMed Web of Science ®Google Scholar
• Goldklang MP, Tekabe Y, Zelonina T, et al. Single-photon emission computed tomography/computed tomography imaging of RAGE in smoking-induced lung injury [J]. Respir Res. 2019;20(1):116.
   PubMed Web of Science ®Google Scholar
• LEE H, PARK JR, KIM WJ, et al. Blockade of RAGE ameliorates elastase-induced emphysema development and progression via RAGE-DAMP signaling [J]. FASEB J. 2017;31(5):2076–2089.
   PubMed Web of Science ®Google Scholar
• CHEN M, WANG T, SHEN Y, et al. Knockout of RAGE ameliorates mainstream cigarette smoke-induced airway inflammation in mice [J]. Int Immunopharmacol. 2017;50:230–235.
   PubMed Web of Science ®Google Scholar
• CHEN L, WANG T, Guo L, et al. Overexpression of RAGE contributes to cigarette smoke-induced nitric oxide generation in COPD [J]. Lung. 2014;192(2):267–275.
   PubMed Web of Science ®Google Scholar
• Waseda K, Miyahara N, Taniguchi A, et al. Emphysema requires the receptor for advanced glycation end-products triggering on structural cells [J]. Am J Respir Cell Mol Biol. 2015;52(4):482–491.
   PubMed Web of Science ®Google Scholar
• Allam V, Faiz A, LAM M, et al. RAGE and TLR4 differentially regulate airway hyperresponsiveness: implications for COPD [J]. Allergy. 2021;76(4):1123–1135.
   PubMed Web of Science ®Google Scholar
• Sambamurthy N, Leme AS, Oury TD, et al. The receptor for advanced glycation end products (RAGE) contributes to the progression of emphysema in mice [J]. PLoS One. 2015;10(3):e0118979.
   PubMed Web of Science ®Google Scholar
• DOWNS CA, JOHNSON NM, Tsaprailis G, et al. RAGE-induced changes in the proteome of alveolar epithelial cells [J]. J Proteomics. 2018;177:11–20.
   PubMed Web of Science ®Google Scholar
• Sanders KA, Delker DA, HUECKSTEADT T, et al. RAGE is a critical mediator of pulmonary oxidative stress, alveolar macrophage activation and emphysema in response to cigarette smoke [J]. Sci Rep. 2019;9(1):231.
   PubMed Web of Science ®Google Scholar
• Robinson AB, JOHNSON KD, BENNION BG, et al. RAGE signaling by alveolar macrophages influences tobacco smoke-induced inflammation [J]. Am J Physiol Lung Cell Mol Physiol. 2012;302(11):L1192–1199.
   PubMed Web of Science ®Google Scholar
• REYNOLDS PR, Schmitt RE, KASTELER SD, et al. Receptors for advanced glycation end-products targeting protect against hyperoxia-induced lung injury in mice [J]. Am J Respir Cell Mol Biol. 2010;42(5):545–551.
   PubMed Web of Science ®Google Scholar
• Demeo DL, SILVERMAN EK. Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk [J]. Thorax. 2004;59(3):259–264.
   PubMed Web of Science ®Google Scholar
• CHO MH, CASTALDI PJ, Hersh CP, et al. A genome-wide association study of emphysema and airway quantitative imaging phenotypes [J]. Am J Respir Crit Care Med. 2015;192(5):559–569.
   PubMed Web of Science ®Google Scholar
• CASTALDI PJ, CHO MH, Litonjua AA, et al. The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility [J]. Am J Respir Cell Mol Biol. 2011;45(6):1147–1153.
   PubMed Web of Science ®Google Scholar
• HANCOCK DB, Eijgelsheim M, Wilk JB, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function [J]. Nat Genet. 2010;42(1):45–52.
   PubMed Web of Science ®Google Scholar
• REPAPI E, Sayers I, Wain LV, et al. Genome-wide association study identifies five loci associated with lung function [J]. Nat Genet. 2010;42(1):36–44.
   PubMed Web of Science ®Google Scholar
• YANG J, ZHOU H, LIANG B, et al. Association of five genetic variants with chronic obstructive pulmonary disease susceptibility and spirometric phenotypes in a Chinese Han population [J]. Respirology. 2014;19(2):262–268.
   PubMed Web of Science ®Google Scholar
• POUWELS SD, Klont F, Kwiatkowski M, et al. Cigarette smoking acutely decreases serum levels of the chronic obstructive pulmonary disease biomarker sRAGE. Am J Respir Crit Care Med. 2018 Dec 1 198(11):1456–1458.
   PubMed Web of Science ®Google Scholar
• Smith DJ, Yerkovich ST, Towers MA, et al. Reduced soluble receptor for advanced glycation end-products in COPD [J]. Eur Respir J. 2011;37(3):516–522.
   PubMed Web of Science ®Google Scholar
• Gopal P, Reynaert NL, Scheijen JL, et al. Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD [J]. Respir Res. 2014;15(1):24.
   PubMed Web of Science ®Google Scholar
• Hoonhorst SJ, Lo Tam Loi AT, POUWELS SD, et al. Advanced glycation endproducts and their receptor in different body compartments in COPD [J]. Respir Res. 2016;17(1):46.
   PubMed Web of Science ®Google Scholar
• CHENG DT, KIM DK, COCKAYNE DA, et al. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease [J]. Am J Respir Crit Care Med. 2013;188(8):948–957.
   PubMed Web of Science ®Google Scholar
• Coxson HO, Dirksen A, Edwards LD, et al. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study [J]. Lancet Respir Med. 2013;1(2):129–136.
   PubMed Web of Science ®Google Scholar
• GOPAL P, Rutten EP, Dentener MA, et al. Decreased plasma sRAGE levels in COPD: influence of oxygen therapy [J]. Eur J Clin Invest. 2012;42(8):807–814.
   PubMed Web of Science ®Google Scholar
• SUKKAR MB, Wood LG, Tooze M, et al. Soluble RAGE is deficient in neutrophilic asthma and COPD [J]. Eur Respir J. 2012;39(3):721–729.
   PubMed Web of Science ®Google Scholar
• PARK SJ, Kleffmann T, Hessian PA. The G82S polymorphism promotes glycosylation of the receptor for advanced glycation end products (RAGE) at asparagine 81: comparison of wild-type rage with the G82S polymorphic variant [J]. J Biol Chem. 2011;286(24):21384–21392.
   PubMed Web of Science ®Google Scholar
• KIM SY, SON M, LEE SE, et al. High-mobility group box 1-induced complement activation causes sterile inflammation [J]. Front Immunol. 2018;9:705.
   PubMed Web of Science ®Google Scholar
• YANG H, WANG H, ANDERSSON U. Targeting inflammation driven by HMGB1 [J]. Front Immunol. 2020;11:484.
   PubMed Web of Science ®Google Scholar
• Gorgulho CM, Romagnoli GG, Bharthi R, et al. Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1 [J]. Front Immunol. 2019;10:1561.
   PubMed Web of Science ®Google Scholar
• Pisetsky DS, Gauley J, Ullal AJ. HMGB1 and microparticles as mediators of the immune response to cell death [J]. Antioxid Redox Signal. 2011;15(8):2209–2219.
   PubMed Web of Science ®Google Scholar
• WHITTALL-GARCíA LP, TORRES-RUIZ J, Zentella-Dehesa A, et al. Neutrophil extracellular traps are a source of extracellular HMGB1 in lupus nephritis: associations with clinical and histopathological features. Lupus. 2019 Nov;28(13):1549–1557.
   PubMed Web of Science ®Google Scholar
• Stoetzer OJ, Wittwer C, Lehner J, et al. Circulating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy [J]. Expert Opin Biol Ther. 2012;12(Suppl 1):S217–224.
   PubMed Web of Science ®Google Scholar
• ANDERSSON U, Ottestad W, Tracey KJ. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19? Mol Med. 2020;26(1):42.
   PubMed Web of Science ®Google Scholar
• Ferhani N, Letuve S, Kozhich A, et al. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease [J]. Am J Respir Crit Care Med. 2010;181(9):917–927.
   PubMed Web of Science ®Google Scholar
• HOU C, Zhao H, LIU L, et al. High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls [J]. Mol Med. 2011;17(7–8):807–815.
   PubMed Web of Science ®Google Scholar
• Abraham E, Arcaroli J, Carmody A, et al. HMG-1 as a mediator of acute lung inflammation [J]. J Immunol. 2000;165(6):2950–2954.
   PubMed Web of Science ®Google Scholar
• Zou W, HE F, LIU S, et al. PM2.5 Induced the expression of fibrogenic mediators via hmgb1-rage signaling in human airway epithelial cells [J]. Can Respir J. 2018;2018:1817398.
   PubMed Web of Science ®Google Scholar
• Yoshizaki A, Komura K, Iwata Y, et al. Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity [J]. J Clin Immunol. 2009;29(2):180–189.
   PubMed Web of Science ®Google Scholar
• YANG D, CHEN Q, YANG H, et al. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin [J]. J Leukoc Biol. 2007;81(1):59–66.
   PubMed Web of Science ®Google Scholar
• Messmer D, YANG H, Telusma G, et al. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization [J]. J Immunol. 2004;173(1):307–313.
   PubMed Web of Science ®Google Scholar
• GARCIA-ROMO GS, Caielli S, Vega B, et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus [J]. Sci Transl Med. 2011;3(73):73ra20.
   PubMed Web of Science ®Google Scholar
• ZHANG H, QIU SL, TANG QY, et al. Erythromycin suppresses neutrophil extracellular traps in smoking-related chronic pulmonary inflammation [J]. Cell Death Dis. 2019;10(9):678.
   PubMed Web of Science ®Google Scholar
• QIU SL, ZHANG H, TANG QY, et al. Neutrophil extracellular traps induced by cigarette smoke activate plasmacytoid dendritic cells [J]. Thorax. 2017;72(12):1084–1093.
   PubMed Web of Science ®Google Scholar
• Yanai H, BAN T, WANG Z, et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses [J]. Nature. 2009;462(7269):99–103.
   PubMed Web of Science ®Google Scholar
• ISHII KJ, Suzuki K, Coban C, et al. Genomic DNA released by dying cells induces the maturation of APCs [J]. J Immunol. 2001;167(5):2602–2607.
   PubMed Web of Science ®Google Scholar
• Schon MP. Adaptive and innate immunity in psoriasis and other inflammatory disorders [J]. Front Immunol. 2019;10:1764.
   PubMed Web of Science ®Google Scholar
• Tewary P, De La Rosa G, SHARMA N, et al. beta-Defensin 2 and 3 promote the uptake of self or CpG DNA, enhance IFN-alpha production by human plasmacytoid dendritic cells, and promote inflammation [J]. J Immunol. 2013;191(2):865–874.
   PubMed Web of Science ®Google Scholar
• Poli C, Augusto JF, Dauve J, et al. IL-26 confers proinflammatory properties to extracellular DNA [J]. J Immunol. 2017;198(9):3650–3661.
   PubMed Web of Science ®Google Scholar
• ZHONG L, HU MM, Bian LJ, et al. Phosphorylation of cGAS by CDK1 impairs self-DNA sensing in mitosis [J]. Cell Discov. 2020;6(1):26.
   PubMed Web of Science ®Google Scholar
• Sirois CM, Jin T, Miller AL, et al. RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA [J]. J Exp Med. 2013;210(11):2447–2463.
   PubMed Web of Science ®Google Scholar
• Proskurina AS, Spaselnikova AV, Ritter GS, et al. Features of monocyte-derived dendritic cells encompassing a rare subpopulation of cells that are capable of natural internalization of extracellular dsDNA [J]. Eur Cytokine Netw. 2019;30(2):43–58.
   PubMed Web of Science ®Google Scholar
• Duvvuri B, LOOD C. Cell-Free DNA as a biomarker in autoimmune rheumatic diseases [J]. Front Immunol. 2019;10:502.
   PubMed Web of Science ®Google Scholar
• Sukjamnong S, CHAN YL, Zakarya R, et al. Effect of long-term maternal smoking on the offspring’s lung health [J]. Am J Physiol Lung Cell Mol Physiol. 2017;313(2):L416–L423.
   PubMed Web of Science ®Google Scholar
• Prantner D, Nallar S, Vogel SN. The role of RAGE in host pathology and crosstalk between RAGE and TLR4 in innate immune signal transduction pathways [J]. FASEB J. 2020;34(12):15659–15674.
   PubMed Web of Science ®Google Scholar
• REYNOLDS PR, KASTELER SD, Cosio MG, et al. RAGE: developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells [J]. Am J Physiol Lung Cell Mol Physiol. 2008;294(6):L1094–1101.
   PubMed Web of Science ®Google Scholar
• Bartling B, Zunkel K, AL-ROBAIY S, et al. Gene doubling increases glyoxalase 1 expression in RAGE knockout mice [J]. Biochim Biophys Acta Gen Subj. 2020;1864(1):129438.
   PubMed Web of Science ®Google Scholar
• LECLERC E, FRITZ G, Vetter SW, et al. Binding of S100 proteins to RAGE: an update [J]. Biochim Biophys Acta. 2009;1793(6):993–1007.
   PubMed Web of Science ®Google Scholar
• LECLERC E, FRITZ G, Weibel M, et al. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains [J]. J Biol Chem. 2007;282(43):31317–31331.
   PubMed Web of Science ®Google Scholar
• Saito T, LIU M, Binnie M, et al. Distinct expression patterns of alveolar “alarmins” in subtypes of chronic lung allograft dysfunction [J]. Am J Transplant. 2014;14(6):1425–1432.
   PubMed Web of Science ®Google Scholar
• Ryckman C, Vandal K, Rouleau P, et al. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion [J]. J Immunol. 2003;170(6):3233–3242.
   PubMed Web of Science ®Google Scholar
• HUANG X, TAN X, LIANG Y, et al. Differential DAMP release was observed in the sputum of COPD, asthma and asthma-COPD overlap (ACO) patients [J]. Sci Rep. 2019;9(1):19241.
   PubMed Web of Science ®Google Scholar
• Railwah C, Lora A, Zahid K, et al. Cigarette smoke induction of S100A9 contributes to chronic obstructive pulmonary disease [J]. Am J Physiol Lung Cell Mol Physiol. 2020;319(6):L1021–l1035.
   PubMed Web of Science ®Google Scholar
• SHARMA A, Kaur S, Sarkar M, et al. The AGE-rage axis and rage genetics in chronic obstructive pulmonary disease [J]. Clin Rev Allergy Immunol. 2021;60(2):244–258.
   PubMed Web of Science ®Google Scholar
• COCKAYNE DA, CHENG DT, Waschki B, et al. Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity [J]. PLoS One. 2012;7(6):e38629.
   PubMed Web of Science ®Google Scholar
• Bagheri V. S100A12: friend or foe in pulmonary tuberculosis?[J]. Cytokine. 2017; 92:80–82.
   PubMed Web of Science ®Google Scholar
• Nakashima A, Carrero JJ, Qureshi AR, et al. Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients [J]. Clin J Am Soc Nephrol. 2010;5(12):2213–2219.
   PubMed Web of Science ®Google Scholar
• Leung JM, Tiew PY, Mac Aogain M, et al. The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD [J]. Respirology. 2017;22(4):634–650.
   PubMed Web of Science ®Google Scholar
• Simpson JL, Baines KJ, Horvat JC, et al. COPD is characterized by increased detection of haemophilus influenzae, streptococcus pneumoniae and a deficiency of bacillus species [J]. Respirology. 2016;21(4):697–704.
   PubMed Web of Science ®Google Scholar
• VAN Zoelen MA, Schouten M, DE Vos AF, et al. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia [J]. J Immunol. 2009;182(7):4349–4356.
   PubMed Web of Science ®Google Scholar
• ACHOUITI A, De Vos AF, De Beer R, et al. Limited role of the receptor for advanced glycation end products during Streptococcus pneumoniae bacteremia [J]. J Innate Immun. 2013;5(6):603–612.
   PubMed Web of Science ®Google Scholar
• Christaki E, OPAL SM, Keith JC, et al. A monoclonal antibody against RAGE alters gene expression and is protective in experimental models of sepsis and pneumococcal pneumonia [J]. Shock. 2011;35(5):492–498.
   PubMed Web of Science ®Google Scholar
• Noto MJ, Becker KW, Boyd KL, et al. RAGE-mediated suppression of interleukin-10 results in enhanced mortality in a murine model of acinetobacter baumannii sepsis. Infect Immun. 2017;85(3). DOI:10.1128/IAI.00954-16.
   Web of Science ®Google Scholar
• ANTONELLI A, Di Maggio S, Rejman J, et al. The shedding-derived soluble receptor for advanced glycation endproducts sustains inflammation during acute Pseudomonas aeruginosa lung infection [J]. Biochim Biophys Acta Gen Subj. 2017;1861(2):354–364.
   PubMed Web of Science ®Google Scholar
• ACHOUITI A, De Vos AF, Van ‘T Veer C, et al. Receptor for advanced glycation end products (RAGE) Serves a Protective Role during Klebsiella pneumoniae - Induced Pneumonia [J]. PLoS One. 2016;11(1):e0141000.
   PubMed Web of Science ®Google Scholar
• Chiappalupi S, Salvadori L, Donato R, et al. Hyperactivated RAGE in comorbidities as a risk factor for severe covid-19-the role of rage-ras crosstalk [J]. Biomolecules. 2021;11(6):876.
   PubMed Web of Science ®Google Scholar
• Leerach N, Harashima A, Munesue S, et al. Glycation reaction and the role of the receptor for advanced glycation end-products in immunity and social behavior [J]. Glycoconj J. 2021;38(3):303–310.
   PubMed Web of Science ®Google Scholar
• Dumitriu IE, Baruah P, Valentinis B, et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products [J]. J Immunol. 2005;174(12):7506–7515.
   PubMed Web of Science ®Google Scholar
• Moser B, Desai DD, Downie MP, et al. Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo [J]. J Immunol. 2007;179(12):8051–8058.
   PubMed Web of Science ®Google Scholar
• Buttari B, Profumo E, Capozzi A, et al. Advanced glycation end products of human β₂ glycoprotein I modulate the maturation and function of DCs [J]. Blood. 2011;117(23):6152–6161.
   PubMed Web of Science ®Google Scholar
• Akirav EM, Henegariu O, PRESTON-HURLBURT P, et al. The receptor for advanced glycation end products (RAGE) affects T cell differentiation in OVA induced asthma [J]. PLoS One. 2014;9(4):e95678.
   PubMed Web of Science ®Google Scholar
• Chen Y, Akirav EM, Chen W, et al. RAGE ligation affects T cell activation and controls T cell differentiation. J Immunol. 2008 Sep 15 181(6):4272–4278.
   PubMed Web of Science ®Google Scholar
• Bierhaus A, M HUMPERTP, Stern DM, et al. Advanced glycation end product receptor-mediated cellular dysfunction [J]. Ann N Y Acad Sci. 2005;1043(1):676–680.
   PubMed Web of Science ®Google Scholar
• ZHANG F, SU X, HUANG G, et al. sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells [J]. Sci Rep. 2017;7(1):14268.
   PubMed Web of Science ®Google Scholar
• ZHANG X, Xie J, SUN H, et al. sRAGE inhibits the mucus hypersecretion in a mouse model with neutrophilic asthma [J]. Immunol Invest. 2021;51:1–14.
   PubMed Web of Science ®Google Scholar
• Giridharan VV, Generoso JS, Collodel A, et al. Receptor for advanced glycation end products (rage) mediates cognitive impairment triggered by pneumococcal meningitis [J]. Neurotherapeutics. 2021;18(1):640–653.
   PubMed Web of Science ®Google Scholar
• BODY-MALAPEL M, Djouina M, Waxin C, et al. The RAGE signaling pathway is involved in intestinal inflammation and represents a promising therapeutic target for inflammatory bowel diseases [J]. Mucosal Immunol. 2019;12(2):468–478.
   PubMed Web of Science ®Google Scholar
• HONG Y, SHEN C, YIN Q, et al. Effects of RAGE-specific inhibitor fps-zm1 on amyloid-β metabolism and ages-induced inflammation and oxidative stress in rat hippocampus [J]. Neurochem Res. 2016;41(5):1192–1199.
   PubMed Web of Science ®Google Scholar
• LEE H, LEE J, HONG SH, et al. Inhibition of RAGE attenuates cigarette smoke-induced lung epithelial cell damage via rage-mediated nrf2/damp signaling [J]. Front Pharmacol. 2018;9:684.
   PubMed Web of Science ®Google Scholar
• LEE S, PIAO C, KIM G, et al. Production and application of HMGB1 derived recombinant RAGE-antagonist peptide for anti-inflammatory therapy in acute lung injury [J]. Eur J Pharm Sci. 2018;114:275–284.
   PubMed Web of Science ®Google Scholar
• PIAO C, KIM G, HA J, et al. Inhalable gene delivery system using a cationic rage-antagonist peptide for gene delivery to inflammatory lung cells [J]. ACS Biomater Sci Eng. 2019;5(5):2247–2257.
   PubMed Web of Science ®Google Scholar
• PIAO C, Zhuang C, Choi M, et al. A RAGE-antagonist peptide potentiates polymeric micelle-mediated intracellular delivery of plasmid DNA for acute lung injury gene therapy [J]. Nanoscale. 2020;12(25):13606–13617.
   PubMed Web of Science ®Google Scholar
• Hwang YH, KIM MJ, LEE YK, et al. HMGB1 modulation in pancreatic islets using a cell-permeable A-box fragment [J]. J Control Release. 2017;246:155–163.
   PubMed Web of Science ®Google Scholar
• Zheng L, ZHU Q, XU C, et al. Glycyrrhizin mitigates radiation-induced acute lung injury by inhibiting the HMGB1/TLR4 signalling pathway [J]. J Cell Mol Med. 2020;24(1):214–226.
   PubMed Web of Science ®Google Scholar